- Social Sciences - 17:00 Prenatal screening for Down’s syndrome seen as ‘routine practice’
- Medicine - 11:00 Tiny ‘cages’ to keep vaccine supplies safe
- Environment - Apr 21 Earth day: Imperial event brings together experts to tackle air pollution
- Medicine - Apr 20 How gut bacteria change cancer drug activity
- Life Sciences - Apr 20 Brain’s "hand area" used by other body parts in people born with one hand
- Medicine - Apr 20 Centres for the UK Dementia Research Institute announced
- Medicine - Apr 20 Imperial wins bid to host new UK Dementia Research Institute centre
- Medicine - Apr 20 Cycling to work may cut your risk of premature death by 40%
- Medicine - Apr 20 £13m dementia research centre
- Medicine - Apr 19 CRT Pioneer Fund, Cancer Research UK and NCI Collaborate to boost research against the ’undruggable’ RAS
- Business - Apr 19 How ‘frugal innovation’ can fight off inequality
- Business - Apr 19 Opinion: How ‘frugal innovation’ can fight off inequality
Liverpool spin-out gets further funding boost for bedside sepsis test
A University of Liverpool spin-out company, Sepsis Limited has secured further funding support to test a point of care diagnostic tool for the early detection of sepsis.
The Small Business Research Initiative for Healthcare ( SBRI Healthcare ), led by the Academic Health Science Networks ( AHSNs ), has awarded the company £100,000 for the first phase of testing a working prototype of a hand held device that will be used at the patient bedside for rapid diagnosis and treatment of sepsis.
The award is part of an NHS England initiative aimed at helping healthcare organisations to improve their flow of patients.
Often referred to as blood poisoning, sepsis is the major cause of death worldwide. In the UK, approximately 100,000 people are admitted to hospital with sepsis and around 37,000 people will die as a result of the condition.
Sepsis Limited, which was spun out in 2010, is founded on the ground breaking research of blood specialist Professor Cheng-Hock Toh from the University’s Institute of Infection and Global Health.
The company’s hand-held device can detect abnormal blood chemistry due to bacterial sepsis within minutes of sampling and before standard physiological sepsis is diagnosed. It has been designed to frequently monitor progression of symptoms with a view to improve and measure the appropriate use of antibiotics and collectively meet objectives of the Department of Health’s UK Five Year Antimicrobial Resistance Strategy 2013-2018 .
Professor Toh, who also provides direct patient care at the Royal Liverpool University Hospital, said: ‘This new funding is an important step in helping us to translate our research into a bedside test that can quickly diagnose life-threatening sepsis, improve antibiotic usage, and ultimately save lives.’
Last job offers
- Medicine/Pharmacology - 17.4
Lee Placito Professorship of Gastroenterological Disease
- Medicine/Pharmacology - 17.4
Professorship of Biomaterials
- Medicine/Pharmacology - 11.4
Chair in Musculoskeletal Pain and Rehabilitation - 56827
- Medicine/Pharmacology - 8.4
- Medicine/Pharmacology - 3.4
Professor, Reader or Senior Lecturer (depending on experience)
- Medicine/Pharmacology - 27.3
Chair in Dental Education and Head of Continuing Professional Development
- Medicine/Pharmacology - 24.3
Chair in Ageing
- Medicine/Pharmacology - 15.3
Professorship of Oncological Imaging